MARKET WIRE NEWS
  1. Home
  2. Stock
  3. TEVA
  4. News
  5. Teva Pharmaceutical Industries Limited Teva Discusse
TEVA
Quote
Short
News
Articles
Message Board

Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript

Source: SeekingAlpha

2026-02-17 10:54:57 ET

Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results February 17, 2026 8:00 AM EST...

Read the full article on Seeking Alpha

For further details see:

Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results Transcript
Teva Pharmaceutical Industries Limited American Depositary Shares

NASDAQ: TEVA

TEVA Trading

-1.98% G/L:

$30.89 Last:

4,413,165 Volume:

$31.38 Open:

mwn-app Ad 300

TEVA Latest News

March 06, 2026 02:20:00 pm
The 3 Best Stocks to Invest $1,000 in Right Now
March 04, 2026 02:07:00 pm
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today
March 04, 2026 04:26:00 am
Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding
March 03, 2026 05:00:00 pm
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

TEVA Stock Data

$39,421,335,208
1,138,314,769
0.04%
264
N/A
Pharmaceuticals
Healthcare
https://www.tevapharm.com
IL
Tel Aviv

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App